Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry (“MS”) instruments, designed to improve the efficiency of pharmaceutical (“Pharma”) R&D, announces a trading update as it approaches its year end. Overview It is expected that EBITDA and pre-tax profit for 2016 will be broadly in line with market expectations at the time of […]